The process of slimming appears to turn into a stressful event because there is a tendency to jump from one life style behavior, eating plan or exercise program to another. Well, it turned out that some people benefitted immensely from prescription weight loss pills, particularly since they can provide that extra motivation. Not even the pills are the same – A product that may be effective on one is not the same as that on the other.
In this guide the reader will discover what prescription weight loss pills are currently available, what work they do, if they are safe and if they are suitable for specific clients.
What are the prescription weight loss pills?
There are prescription weight loss supplements which are the drugs that have been approved by Food and Drug Administration for anyone with obesity or related diseases.
They are often used in conjunction with other treatment procedures, particularly the low calorie diet and the physical activity to deliver the best results.
Prescription Medications That Rank High for Weight Loss
Here are the standout options for prescription weight-loss pills, based on their popularity, efficacy, and safety:
1. Wegovy (Semaglutide)
How it works:
In particular, Wegovy belongs to the brands of GLP-1 receptor agonists with the main function of imitating the natural hormone for the management of food consumption.
Effectiveness:
The research shows that the people who consumed the product shed 15 to 20% of their weight on average during the year with other diets and exercises.
Who it’s for:
Obese clients with a BMI of thirty and above or those with BMI of twenty seven and above, but present other aspects of metabolic syndrome.
Side effects:
Headache, vomiting, nausea, diarrhea and dizziness.
Regarding obesity, Wegovy is new to the patients, who should shed a significant amount of weight for medical purposes.
2. Ozempic (Semaglutide)
How it works:
Ozempic is also bound with GLP-1 receptors, but is effective solely for type 2 diabetes. This is normally used off-label since some positive emotion in regard to efficacy on weight reduction schemes has been observed.
Effectiveness:
Many of the users, by the usage, affirm that they have been able to shed off up to 10- 15% of their body weight in one year of use.
Who it’s for:
Excess weight or obesity impacted people with type 2 diabetes.
Side effects:
Abdominal complications and low blood sugar levels.
3. Qsymia (Phentermine and Topiramate)
How it works:
Qsymia includes a phentermine – appetite suppressant and topiramate which produces the feeling of fullness.
Effectiveness:
It is also evident from the studies that patients can actually shed an average of 10 percent of total body mass in a year.
Who it’s for:
Obese adult that is any individual with a BMI of 30 and above, or a BMI of 27 and above with one or more obesity associated conditions.
Side effects:
Chest discomfort, dry mouth, dizziness, constipation, insomnia.
This two-in-one capsule is more useful to be used in persons with appetite control issues or persons who take snacks in-between their major meals.
4. Contrave (Naltrexone and Bupropion)
How it works:
The Contrave combination is made up of naltrexone – used to treat addictions and bupropion – used to treat depression. Together, they are used to reduce appetite as well as cravings.
Effectiveness:
Coming with it, users have reported losing 5-10% of their body weight in the first six to twelve months.
Who it’s for:
All people who have a tendency to turn to food whenever they have some feelings or stress.
Side effects:
Vomiting, migraine and elevated hypertension.
Contrave shows the best side of addressing the issue concerning the psychological aspect of overeating.
5. Saxenda (Liraglutide)
How it works:
There is however another drug in the class of GLP-1 receptor agonist Known as Saxenda which deals with appetite and gastric motility and slows the rate of gastric emptying.
Effectiveness:
Long-term use leads to weight reduction to the extent of 5-10 % within a year.
Who it’s for:
Obese adults and adolescents and others who have obesity related complications.
Vomiting, nausea and diarrhoea.
This was previously given only once a day and is well suited for patients, who require chronic therapy for obesity.
6. Rybelsus (Oral Semaglutide)
How it works:
Thus, Rybelsus is semaglutide in oral form that provides equivalent appetite suppressing effect without having to inject the substance.
Effectiveness:
It offers the same level of obesity management benefit as other injectable drugs such as Wegovy and Saxenda.
Who it’s for:
Bothered patients during injections and those who prefer tablets or capsules intake.
Side effects:
Such symptoms as abdominal pains, vomiting and diarrhoea.
It is appropriate for people who have needle phobia but need a lot of encouragement to make them lose significant weight.
7. Mounjaro (Tirzepatide)
How it works:
It also activates receptors of GLP-1 and GIP which optimally enhances the drug’s effectiveness of diminishing the appetite and raising metabolic rates.
Effectiveness:
Compared to this, patients say that in the real-life trials, the weight loss can only be between 15-20% and is targeted at patients who have undergone a similar procedure.
Who it’s for:
Individuals suffering from type II diabetes or having extreme obesity.
Side effects:
Gastrointestinal diseases and hypoglycemia.
This two-step put Monjaro in a better stead in terms of supporting full weight loss to anybody who may require a very severe kind of help.
8. Phentermine
How it works:
Phentermine is related to the amphetamine group and exert its action on the central nervous system to reduce appetite. This drug is in some cases used in weight loss management programs for a short term purpose.
Effectiveness:
The users are able to reduce their body weight by 5-10% in 3 months or 3-6 months further if they consume along with low calorie and exercise.
Who it’s for:
Adults with BMI of 30 or more, or BMI of 27 or more when accompanied by high blood pressure, diabetes or high cholesterol.
Side effects:
Palpitation, dryness of oral cavity, sleeplessness and anxiety.
Phentermine is famous for its low prices and short-term effect – as an agent able to trigger weight loss processes.
Other Options: What Makes Them Not Among the Best
Laxatives
Even though some people use laxatives as weight loss products they do not have any way of reducing body fat. But they only cause water weight loss which is both non sustainable and not healthy for your body in the process.
Why they’re not the best: Absence of efficiency in fat loss and several negative impacts on body of a human.
Topamax (Topiramate)
Patients take Topamax for epilepsy, yet many patients use it as a slimming product since the drug makes people stop eating. It is, however, more widespread in a compound with other active ingredients as in the case of Qsymia. In this case it may not have such a strong effect on the process however, it is good for when other therapies are also performed.
Why it’s not the best: Better in Qsymia in combination with phentermine.
Zepbound
A newer prescriptive medication that one can hardly turn their attention to is known as Zepbound. Yes, it has potential, but it still is not as filled with clinical trials and studies as one might find with more common prescriptions like Wegovy or Ozempic.
It was moved to the second-line in its treatment until more phase III trials confirmed its overall safety and efficacy for the patients.
Why it’s not the best: Less amount of clinical trial or clinical data.
Honorable Mentions
While not the prescription pills, these alternatives deserve a recognition for their potential weight loss benefits:
- Berberine: This supplement is even called the ‘natural Ozempic’ since it has a similarity to GLP-1 agonists.
- Vitamin D: It aids in management of obesity and many other physiological functions of the organism.
- Fenugreek and Turmeric: It can help control the process of metabolism and the appetite.
- Weight-Loss Gummies and Patches: These are very effective, they are available without a prescription, but are not as effective as those that require a prescription.
The Best Weight Loss Pill: How to Pick the Right One
Choosing the best weight-loss pill depends on several factors:
Health Conditions:
Ozempic or Mounjaro may be selected, if necessary, if you have diabetes.
Weight-Loss Goals:
For the weight loss goal of over 5% you may try with Wegovy or Qsymia.
Convenience:
If you have complications with injections then you can try to take Rybelsus or Contrave instead.
The Bottom Line
It is thus pertinent to mention, that prescription weight loss products are good asset in combating obesity. Some of the drugs include; Wegovy, Ozempic, Qsymia and Saxenda which are at the forefront looking for a solution for millions of people living with obesity. These are not magic pills – they should be consumed, at best, together with proper diet, exercise routine, and continuous consultations with a healthcare professional.
When deciding on which medication to take it is advisable to seek the opinion of your doctor to whether the medication to be taken is good for the intended purpose.
- Tayyaba, T. S., & Doultani, P. R. (2023). Tirzepatide (Mounjaro)-a novel Pharmacotherapeutic Agent for Obesity. JPMA, 2_JPMA.
- Nair, R., & Maseeh, A. (2012). Vitamin D: The “sunshine” vitamin. Journal of pharmacology and pharmacotherapeutics, 3(2), 118-126.
- Wajid, I., Vega, A., Thornhill, K., Jenkins, J., Merriman, C., Chandler, D., … & Kaye, A. D. (2023). Topiramate (Topamax): Evolving role in weight reduction management: a narrative review. Life, 13(9), 1845.
- Portalatin, M., & Winstead, N. (2012). Medical management of constipation. Clinics in colon and rectal surgery, 25(01), 012-019.
- Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., … & Morton, S. C. (2005). Meta-analysis: pharmacologic treatment of obesity. Annals of internal medicine, 142(7), 532-546.
- Hendricks, E. J., & Greenway, F. L. (2011). A study of abrupt phentermine cessation in patients in a weight management program. American journal of therapeutics, 18(4), 292-299.
- Wojtara, M., Mazumder, A., Syeda, Y., & Mozgała, N. (2023). Glucagon‐Like Peptide‐1 Receptor Agonists for Chronic Weight Management. Advances in Medicine, 2023(1), 9946924.
- Elliott, W., & Chan, J. (2019). Semaglutide tablets (Rybelsus). Internal Medicine Alert, 41(20).
- Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., … & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
- Greenway, F. L., Fujioka, K., Plodkowski, R. A., Mudaliar, S., Guttadauria, M., Erickson, J., … & Dunayevich, E. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605.
- Tong, E. K., Carmody, T. P., & Simon, J. A. (2006). Bupropion for smoking cessation: a review. Comprehensive therapy, 32, 26-33.
- Berg, B. J., Pettinati, H. M., & Volpicelli, J. R. (1996). A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug Safety, 15, 274-282.
- Finkelstein, E. A., Kruger, E., & Karnawat, S. (2015). Cost-effectiveness analysis of Qsymia for weight loss. Pharmacoeconomics, 33, 699-706.
- Lonneman Jr, D. J., Rey, J. A., & McKee, B. D. (2013). Phentermine/Topiramate extended-release capsules (qsymia) for weight loss. Pharmacy and Therapeutics, 38(8), 446.
- Altywaiq, A. M., Alanzi, T. S. N., Al-Ruqi, A. R. M., Alotaibi, W. N., Alnughaythir, A. A. I., Alshammari, S. M., … & Alkhalifah, S. S. (2022). Ozempic and Wegovy for Weight Loss, Pharmacological Component and Effect. Journal of Namibian Studies: History Politics Culture, 31, 167-180.
- Frías, J. P., Auerbach, P., Bajaj, H. S., Fukushima, Y., Lingvay, I., Macura, S., … & Buse, J. B. (2021). Efficacy and safety of once-weekly semaglutide 2· 0 mg versus 1· 0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial. The Lancet Diabetes & Endocrinology, 9(9), 563-574.
- Han, S. H., Safeek, R., Ockerman, K., Trieu, N., Mars, P., Klenke, A., … & Sorice-Virk, S. (2024). Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: a Google Trends analysis. Aesthetic Surgery Journal, 44(1), 60-67.
- Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
- National Center for Biotechnology Information. (n.d.). [Title of the specific section or chapter, if available]. In NCBI Bookshelf. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK564659/
- Muthusamy, G. (2023). Pharmaceutical research: Recent advances and trends (Vol. 6) [eBook]. Retrieved from https://www.researchgate.net/profile/Gayathiri-Muthusamy/publication/384701730_Pharmaceutical_Research_Recent_Advances_and_Trends_Vol_6_-_ebook_1/links/6704c31ab753fa724d64a0cd/Pharmaceutical-Research-Recent-Advances-and-Trends-Vol-6-ebook-1.pdf#page=115
- Eli Lilly and Company. (2023). Lilly’s tirzepatide achieved 15.7% weight loss in adults with obesity or overweight. Retrieved from https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-achieved-157-weight-loss-adults-obesity-or
- U.S. Food and Drug Administration. (2014). Prescribing information for [drug name]. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206321orig1s000lbl.pdf
Read this Next
Do Weight Loss Patches Work?
Weight loss patches are designed for easy weight loss and promise that their active substances are absorbed by skin—transdermally....
Does Medicare Cover Wegovy, Zepbound, and Other Weight-Loss Medications?
Overweight and obesity are among the most important issues affecting health of population in the United States, especially of...
Zepbound vs Wegovy
If you’ve been exploring weight loss options, you might have come across two newer treatments: ZepBound and Wegovy. These...
Zepbound vs Ozempic
Zepbound, also known generically as tirzepatide, and Ozempic, which includes semaglutide, fall under the incretin mimetics family of drugs,...